Mr Merselis will also serve as a member of the company’s board of directors.
Most recently, Mr Merselis served as president and CEO of HemoSense, a point-of-care diagnostics company. Prior to his tenure at HemoSense, Mr Merselis served as president and CEO of Micronics, a microfluidics company.
In addition, Mr Merselis held a number of positions over 22 with Boehringer Mannheim Diagnostics.
Gary Kurtzman, chairman of the board of Alverix, said: “Jim has a superior track record of building businesses and creating value. His extensive industry experience and expertise will be an asset to Alverix in achieving its fullest potential and ensuring that its innovative technology is fully and rapidly leveraged.”